Dr Lee Chien-Chang
Deputy Director of Intelligent Healthcare and Professor of Emergency Medicine, National Taiwan University Hospital, Taiwan
Dr Cynthia Papendick
Associate Professor of Adelaide Medical School and Emergency Physician, Royal Adelaide Hospital, Australia
 

At the forefront of Acute Coronary Syndrome management in ED

Endorsed by:
MALAYSIAN COLLEGE OF EMERGENCY PHYSICIANS
TAIWAN SOCIETY OF EMERGENCY MEDICINE

Supported by:
NATIONAL HEART ASSOCIATION OF MALAYSIA

Agenda

Acute Coronary Syndrome mortality remains high. There is a need for rapid, accurate and safe diagnosis specifically in the Emergency Department (ED) setting. The hs Tn Webinar aims to highlight the value of the high-sensitivity cardiac troponin (hs-cTn) 0-hour/1-hour algorithm in effectively triaging patients presenting with suspected AMI to the ED to either rule-out or rule-in classifications.

Hear from Dr Chien-Chang Lee, an Associate Professor of Emergency Medicine at the National Taiwan University in Taiwan and Dr Cynthia Papendick, Emergency Physician, Emergency Department of Royal Adelaide Hospital in Australia on their experience in implementation and the new evidence (including latest ESC 2020 guidelines) on the use of hs-cTn 0h/1h algorithm in the ED.

TIME

TOPIC

MODERATOR / SPEAKERS


1200-1235
  • Welcome and Introduction
  • hs Tn 0h/1h algorithm in ED-New Evidence Updates
  • How to differentiate myocardial injury and infarction in cases of Sepsis, AMI, Renal Failure in the ED.
Dr Chien-Chang Lee

1220-1300
High-Sensitivity Troponin in Clinical Practice: Successful implementation and ESC 2020 guideline updates
Dr Cynthia Papendick

President of APSC Cofound of digital trends in Asia

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023
Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi